Protea Biosciences Group (PRGB) stock price, revenue, and financials

Protea Biosciences Group annual revenue was $2.45 m in FY 2016

$328.1 K

Protea Biosciences Group Revenue Q2, 2017
Protea Biosciences Group Gross profit (Q2, 2017)-61.4 K
Protea Biosciences Group Gross profit margin (Q2, 2017), %(18.7%)
Protea Biosciences Group Net income (Q2, 2017)-5.5 M
Protea Biosciences Group EBIT (Q2, 2017)-1.4 M
Protea Biosciences Group Cash, 30-Jun-201782.7 K

Protea Biosciences Group Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.2m1.8m2.0m2.4m

Revenue growth, %

45%13%22%

Cost of goods sold

871.9k721.7k1.7m

Gross profit

896.4k1.3m741.0k

Gross profit Margin, %

51%64%30%

R&D expense

2.8m1.5m602.3k

Operating expense total

2.8m1.5m602.3k

EBIT

(10.3m)(10.7m)(7.1m)(5.5m)

EBIT margin, %

(844%)(605%)(356%)(225%)

Interest expense

746.2k745.3k1.6m2.0m

Pre tax profit

(11.4m)(11.5m)(9.6m)(15.6m)

Income tax expense

Net Income

(11.4m)(11.5m)(9.6m)(15.6m)

Protea Biosciences Group Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.1m322.9k6.5k78.7k

Accounts Receivable

435.3k119.2k195.8k1.3m

Inventories

465.3k161.3k111.1k92.2k

Current Assets

2.5m931.3k411.6k728.9k

PP&E

2.9m3.0m2.6m2.5m

Total Assets

5.4m4.0m3.0m3.2m

Accounts Payable

759.0k1.3m1.3m1.8m

Current Liabilities

6.2m7.8m9.6m15.6m

Common Stock

6.5k6.7k13.3k16.2k

Preferred Stock

334.0

Additional Paid-in Capital

55.4m64.3m71.3m81.1m

Retained Earnings

(69.9m)(79.6m)(95.2m)

Total Equity

(3.0m)(5.6m)(8.3m)(14.1m)

Financial Leverage

-1.8 x-0.7 x-0.4 x-0.2 x

Protea Biosciences Group Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(11.4m)(11.5m)(9.6m)(15.6m)

Depreciation and Amortization

844.9k825.8k686.8k678.5k

Accounts Receivable

(127.0k)(198.1k)(260.1k)

Inventories

439.9k304.0k146.6k41.7k

Accounts Payable

(2.0m)810.6k148.6k458.0k

Cash From Operating Activities

(10.2m)(7.3m)(5.6m)(4.2m)

Cash From Investing Activities

(477.9k)1.0m1.5m

Long-term Borrowings

(858.2k)

Cash From Financing Activities

11.7m6.5m4.2m2.8m

Interest Paid

383.3k319.9k352.1k317.6k

Protea Biosciences Group Ratios

USDY, 2017

Revenue/Employee

8.4k

Financial Leverage

-0.2 x

Protea Biosciences Group Employee Rating

3.15 votes
Culture & Values
3.3
Work/Life Balance
3.3
Senior Management
3.5
Salary & Benefits
4.1
Career Opportunities
2.2
Source